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Objective: To assess improvement in clinical outcomes and patient satisfaction of a financially incentivized weight loss competition 
adjunct to a currently established pharmacist-directed employee wellness program. Design: Retrospective, cohort, pilot study 
Setting: 6 independent community pharmacy chain locations, two long-term care pharmaǇ ůŽĐĂƚŝŽŶƐ and a pharmacy corporate office 
in northwest and central Missouri, from January 2013 to April 2013. Participants: 24 benefit-eligible patients employed by the self- 
insured pharmacy chain. Intervention: A financially incentivized weight loss competition focusing on healthy lifestyle practices was 
implemented at nine pharmacy locations over an eight week period. Main outcome measure(s): Change from baseline in mean total 
cholesterol, serum triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), systolic     
blood pressure (SBP), diastolic blood pressure (DBP), weight, and body mass index (BMI). Patient satisfaction was also assessed after 
completion. Results: 24 patients completed the competition. The average weight loss among all participants was 10 ± 7.3 pounds. A 
mean decrease in serum triglycerides was significant at 36.9 mg/dL per participant (p<0.05) ŝŶ ƐƵďŐƌŽƵƉ ĂŶĂůǇƐŝƐ. Pearson correlation 
coefficients between healthy lifestyle practice points earned and clinical measurements were significant for total cholesterol (r = -0.54), 
LDL-C (r = -0.50) and triglycerides (r = -0.49). Conclusion: The implementation of a financially incentivized weight loss competition provided 
significant short-term weight loss to a patient population that was already enrolled in an established pharmacist-directed employee 
wellness program and had not shown clinical improvement prior to the intervention. Overall the patients were satisfied, felt 




The prevalence of Americans who are overweight or obese 
has increased significantly since the 1960s.1 National survey 
data collected between 2009 and 2010 found that nearly 70% 
of all adults in the United States are overweight or obese.2 
These observations are not surprising as Americans are living 
busier, more fast-paced, and technology-dependent lifestyles 
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Obesity is a multifactorial problem stemming from many 
genetic and environmental factors.3 The largest of the 
modifiable contributing factors in Americans are lack of 
physical activity and easy accessibility to nutritionally poor 
foods.4,5 Despite an increased focus on the issues surrounding 
obesity, little has been accomplished to improve prevention 
and treatment of the disease. However, complications are 
confounded by the simple truth that many occurrences of 
success or failure in management of non-genetically 
attributed obesity rests with the individual to develop a 
motivational force to create an established behavior change.6 
 
Obesity is a growing concern in the health care system due to 
the increased costs associated with developing obesity- 
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related chronic diseases such as diabetes, hypertension, heart 
disease, stroke, gallstones, and colon cancer.7,8 It is estimated 
that obesity in the United States results in $147 billion of 
direct medical costs a.n.nually.9 Obesity also increases the 
patient's risk of all-cause mortality when compared to people 
of normal body weight.10 
 
In order to lower health care costs, improve employee well- 
being, and create a health-conscious atmosphere, Red Cross 
Pharmacy, Inc. developed an employee wellness program 
(EWP) in 2010 designed to utilize pharmacist coaching and 
monitoring to improve overall health and wellness. Utilizing 
pharmacist’s clinical expertise and knowledge of 
pharmacological and non-pharmacological disease state 
therapy, previous research has shown that pharmacist- 
directed services can have a significant effect on patient’s 
clinical, humanistic, and economic outcomes.11-21 A study by 
DiDonato, et al. demonstrated that pharmacist-directed 
wellness coaching provided significant improvements in 
cardiovascular risk.22  Pharmacist providers of the DiDonato, 
et al. study provided education and coaching for patients 
categorized into cholesterol, hypertension, diabetes, and 
weight monitoring groups. Point-of-care testing utilizing 
Cholestech LDX [Alere] and physical assessment were utilized 
to monitor progress and guide education and coaching 
sessions. The study showed a significant improvement in 
clinical outcomes for all monitoring groups except weight 
loss, which prompted further study. 
 
An alternative successful strategy for improving patient 
outcomes is the use of financial incentives. Previous studies 
have shown financial incentives and group support programs 
to be successful methods for patients to lose weight and to 
reduce the risk of developing chronic diseases in the short- 
term. Though encouraging, prevention of obesity requires 
life-long commitment and support. No study to date has 
assessed a successful strategy to facilitate weight loss for a 
period greater than 36 weeks. 23-27 
 
Inspired by the short-term success of financial incentives and 
ongoing support of the EWP, this study attempts to combine 
methods with desires of improving long-term clinical 
outcomes in the DiDonato et al. study population, which 
previously showed no significant improvement in weight loss. 
This is the first pilot study to look at the effect of a financially 
incentivized competition facilitated by a pharmacist-directed 
EWP on the short-term success on weight loss. 
 
Objective 
The purpose of this study was to evaluate the short-term 
clinical improvement in mean total cholesterol, serum 
triglycerides, high-density lipoprotein cholesterol (HDL-C), 
low-density lipoprotein cholesterol (LDL-C), systolic blood 
pressure (SBP), diastolic blood pressure (DBP), weight, and 
body mass index (BMI) in patients who completed the 8- 
week, financially incentivized weight loss competition. Patient 
satisfaction was evaluated post-competition. The authors 
hypothesized that the addition of a financially incentivized 
weight loss competition to an already established pharmacist- 
directed EWP would motivate obese and overweight patients 
to lose weight through healthy lifestyle practices thus 
resulting in clinical improvements. 
 
Methods 
This retrospective pilot study was conducted at six Red Cross 
Pharmacy independent community pharmacy chain locations, 
two long-term care pharmacy locations, and a pharmacy 
corporate office between late January 2013 to early April 
2013. The pharmacy corporation is a self-insured, 
independent, small chain of pharmacies located in mostly 
rural communities in northwest and central Missouri. Patients 
were eligible for enrollment if they were 18 years or older, 
non-pregnant, employed by the company, and enrolled in the 
company’s EWP. Patients were aware of the guidelines and 
prize structure for the 8-week competition prior to 
participation with enrollment being voluntary. Pharmacist 
coaches provided pre- and post-study screenings of total 
cholesterol, triglycerides, HDL-C, LDL-C, SBP, DBP, weight,   
BMI and satisfaction surveys for all participants who 
completed the competition. 
 
The study was approved by the University of Missouri– 
Kansas City Adult Health Sciences Institutional Review Board. 
All patients enrolled voluntarily and provided informed 
consent before receiving services. 
 
The weight loss competition 
The 8-week format of the competition was developed based 
on the “8-week Get Healthy Challenge” available at 
www.SixSistersStuff.com and modified to follow the National 
Heart, Lung and Blood Institute guidelines for the clinical 
treatment of obesity.28  Specific healthy lifestyle practices 
were adapted to be consistent with treatment guidelines of 
hypertension, cholesterol, and diabetes.29-31 The healthy 
lifestyle practices included in the study were: adequate water 
intake, regular exercise, adequate consumption of fruits and 
vegetables, maintaining a food log, avoiding sugary snacks, 
contact with another competition participant, and avoidance 
of eating after 9 pm. Minimum water, fruit and vegetable 
requirements were derived from the American Dietary 
Guidelines and the practice of avoiding eating after 9 pm is 
recognized to promote healthy sleep hygiene.32, 33 Healthy 
lifestyle practices were then modified for patient 
understanding and generalized to fit all patient populations. 
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Once the healthy lifestyle practices were defined, they were 
organized into daily and weekly goals and assigned point 
values (Figure 1). Starting on the second week, one of the 
healthy lifestyle practices was doubled in point value for one 
week, alternating for subsequent weeks, to encourage 
participants to vary their focus and utilize all of the different 
healthy lifestyle practices. Patients received the full amount  
of points if the healthy lifestyle goal was achieved for the day. 
Partial point totals were not given. Patients were instructed  
to document their weekly point total and weight each 
Monday by midnight Central Standard Time. The weekly 
reports allowed the investigator to monitor excessive or 
unhealthy weight loss and allowed participants to know how 
they are doing compared to other participants. 
 
To provide the patients with a financial incentive, patients 
participating in the program each deposited $25 into a 
winner’s cash pot. An additional $500 was deposited by the 
pharmacy owner to provide further incentive for EWP 
enrollees to participate. The total cash pot was divided 
between the winners of the weight loss competition. The 
patient who lost the highest percentage of their starting body 
weight received 50% of the total money pot, the second 
highest percentage lost received 30% of the total money pot, 
and the patient who had accumulated the most healthy 
lifestyle practice points received 20% of the total money pot. 
All participants were notified of the prize values and prize 
structure at the beginning of the program. Patients were 
required to report their weights and weekly point totals by 
the defined deadline and to provide documentation that they 
completed the objectives of the healthy lifestyle practices in 
order to be eligible for the financial awards. 
 
Data Collection 
Patients were instructed to keep track of their daily points 
and weekly weights. To provide consistency, patients were 
asked to weigh themselves weekly on the same scale and 
under the same conditions. These conditions were monitored 
by a site coordinator to help facilitate the program and 
enforce uniformity. Once the site coordinator collected the 
data, the data was sent via secure fax to a data collection 
coordinator. Log sheets containing the weekly weights and 
healthy lifestyle point totals were obtained by the  
investigator at the conclusion of the competition for analysis. 
 
As part of the EWP 2013 enrollment, all participants 
completed weight, BMI, blood pressure, and cholesterol 
screenings in January and February. These clinical parameters 
were repeated at the end of the 8-week study period for 
participants who completed the competition. Clinical 
laboratory data were obtained through physical assessment, 
Cholestech LDX [Alere] point-of-care lipid testing and from 
physician or laboratory collections. Each pharmacy followed 
manufacturer recommendations, performed quality control 
testing to ensure reliability of the study data, and had a 
Clinical Laboratory Improvement Amendments certificate of 
waiver to conduct point-of-care testing on site. 
 
All patients who participated in the weight loss competition 
were provided patient satisfaction surveys following the 
completion of the program. Surveys were completed 
anonymously and returned via secure fax to the investigator. 
Patients were asked six questions in regards to their 
perceived personal health and overall satisfaction with the 
program. The questions utilized a 5-point Likert scale ranging 
from 1 (strongly disagree) to 5 (strongly agree). Patients were 
also asked to provide feedback on the competition and to 
make suggestions for the improvement of future weight loss 
competitions. 
 
Clinical data were compiled and de-identified. Following the 
completion of the competition, clinical and demographic data 




The main outcomes of the study were to assess the mean 
changes in clinical data between January 2013 and April 2013. 
The paired t test was used to compare pre- and post- 
competition mean changes in total cholesterol, serum 
triglycerides, HDL-C, LDL-C, SBP, DBP, weight, and BMI for 
study participants. Subgroup analyses divided the study 
population into two groups; those earning more than 1600 
points (80 percent of possible points) and those earning less 
than 1600 points. Pearson correlation coefficients were 
calculated between total points earned and changes in   
clinical data. Mean changes and Pearson correlation 
coefficients were considered statistically significant with an 
alpha of <0.05. Post-study surveys were also compiled at the 
conclusion of the competition to assess patient satisfaction 
and provide feedback. All clinical and patient satisfaction data 
was exported into Microsoft Excel version 2010 (Microsoft, 
Redmond, WA) for statistical analysis. 
 
Results 
Baseline patient demographics for the competition are 
summarized in Table 1. The majority of the participants were 
white women in their late 30s who self-reported exercising 1- 
2 times a week or less prior to starting the competition. 
Nearly half of the patients had obtained a graduate or 
professional degree. 
 
During the enrollment period, 34 patients agreed to 
participate in the study out of 112 patients enrolled in the 
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EWP. Twenty-four of these patients completed the 
competition at the end of the 8-week study period. Pre- and 
post-competition clinical data analysis is summarized in Table 
2. The mean weight loss among the 24 participants was 10 ± 
7.3 pounds. 
 
All patient statistical analysis showed a clinically significant 
mean change in weight (p<0.001) and BMI (p<0.001) among 
all patients (n=24). Pearson correlation coefficients between 
total points earned and changes in five clinical measurements 
(total cholesterol, LDL-C, HDL-C, triglycerides, and diastolic 
blood pressure) were negative, meaning that a higher total in 
points was correlated with a decrease in clinical 
measurements. Pearson correlation coefficients are 
summarized in Table 3. Pearson coefficients for total 
cholesterol (r = -0.54), LDL-C (r = -0.50) and triglycerides (r = - 
0.49) were significant. 
 
Satisfaction survey results are summarized in Table 4. Overall, 
patients agreed that the directions were easy to follow, they 
would participate in the program again, and they would 
recommend the program to others. Patients agreed that they 
felt healthier and would continue to follow the healthy 
lifestyle practices beyond the completion of the program. The 
lowest scaled score was satisfaction in their individual results 
(3.9 ± 1.0). The satisfaction in their individual results was also 
the most varied response among participants. Reasons for 
varied responses were not assessed. 
 
Discussion 
Sustainable and healthy weight loss is most effectively 
accomplished through education, diet and physical activity.28 
The ultimate goal of the competition was to incorporate 
clinically recommended healthy lifestyle practices into the 
daily routines of patients so that they can carry on those 
practices throughout their lives. Patients who followed the 
healthy lifestyle practices most closely, represented by 
patients who earned more “healthy lifestyle points,” showed 
clinically significant improvement in weight and BMI. The 
study also showed this correlation to be statistically 
significant for reductions in total cholesterol, LDL-C and 
triglycerides. This was an interesting observation as most of 
the enrolled patients had already achieved their  
individualized non-weight clinical measurement goals  
through the monitoring and pharmacist coaching provided by 
the EWP and described in the DiDonato, et al study.22 The 
improved clinical outcomes were consistent with guidelines 
that use therapeutic lifestyle changes as the first-line of 
treatment for high cholesterol and blood pressure.29, 30 When 
therapeutic lifestyle changes are applied to weight loss, the 
National Heart, Lung and Blood Institute guidelines 
recommend healthy weight loss between one to two pounds 
per week until the patients desired weight is reached.28 The 
short-term weight loss of this competition was consistent 
with other studies which showed significant weight loss over 
16 , 32 and 36-week study periods. Patients in this study lost 
an average of 10 lbs over 8 weeks compared to the similar 
studies which averaged 14 pounds over 16 weeks, 9 pounds 
over 32 weeks and 10 pounds over 36 weeks.25-27  Other 
studies concluding similar weight loss did not discuss patient 
participation in a EWP or adjunct tool or support system to 
achieve and maintain weight loss in addition to the financial 
incentive, nor did they assess cholesterol and blood pressure 
values. The Kullgren, et al. study focused on group versus 
individual outcomes in weight loss while the John, et al. study 
explored self-funded financial contract for weight loss.26, 27 No 
study to date has developed a successful method to motivate 
and facilitate weight loss for a period greater than 36 weeks 
or has looked at the effect of a financially incentivized 
competition adjunct to a pharmacist-directed EWP on weight 
loss. 
 
Participant data was separated into groups of participants 
earning more than 1600 points and those earning less than 
1600 points to compare those who followed the healthy 
lifestyle guidelines to those who did not. Subgroup analysis of 
participants (n=10) earning at least 1600 points showed a 
decrease in mean clinical measurements post-competition  
but did not achieve statistical significance except in 
triglycerides, with an average decrease of 36.9 ± 33.7 
mg/dL per participant (p<0.001). None of the other 
differences between pre- and post- competition were 
significant except total cholesterol and LDL-C for the under 
1600 points group (n=14). However, a longer and sustaining 
intervention is necessary to potentially show clinically 
significant reductions in cholesterol. 
 
The feedback received from the patient satisfaction surveys 
showed us that patients enjoyed the simplicity of the healthy 
lifestyle practices. The patients stated that the practices were 
easy to follow once a habit was incorporated into daily 
routines. Patients liked knowing what their daily and weekly 
healthy lifestyle practice objectives were because it  
prompted them to make healthy diet choices and motivated 
them to help one another accomplish their personal and 
competition defined goals. Many patients stated that they 
would continue to follow the healthy lifestyle practices 
beyond the completion of the competition. Based on 
feedback from the patient satisfaction survey, the 
competition was well received and successfully integrated in 
the EWP. Patients who dropped out of the program were not 
assessed for reasons of failure nor given satisfaction surveys. 
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In reference to Prochaska and DiClemente’s Transtheoretical 
Model, because these patients were participants in an 
already established EWP, it is likely that those who signed up 
for the challenge were already in the Action or Maintenance 
stage, wanting to continue their weight loss.34  The tools 
provided through the challenge may also have been helpful in 
assisting those in the Preparation stage to transition into 
Action. Offering the challenge multiple times throughout the 
year may provide an opportunity for those in Relapse to 
restart their cycle of change. This model may be helpful in 




The major limitations were small sample size and the short 
length of the study. The sample size was limited by the 
number of employees in the company. The study length was 
limited by the length of the investigator’s residency program 
and the pilot nature of the study. 
 
Another limitation to the study was the competition’s point 
system. The points were developed to objectively measure 
the patient’s ability to follow the guidelines of the healthy 
lifestyle practices and to promote competition. The results 
from the points system were subject to false documentation 
or subjectivity of the participant. Point uniformity of each 
category may have helped prevent the bias of focusing on 
specific healthy life practices. Additionally, the competition 
instructions did not provide patient specific definitions for 
exercise, sugary snacks or fruits and vegetables. Generalized 
healthy lifestyle practices were intentionally simplified to 
provide the patient with the autonomy to make their own 
dietary and exercise choices. This lack of standardized 
definitions was a source of inconsistency between individuals. 
 
All of the patients in the program were enrolled in the EWP 
and many had met their individualized clinical goals for 
cholesterol and blood pressure. Patients enrolled were not 
assessed for the addition or removal of cholesterol and 
hypertensive medications during the course of the 
competition. Patients were also not asked about their 
methods for weight loss as they were encouraged but not 




The limitations above present avenues for improvement and 
future research. Several studies have shown financial 
incentives to be a successful method for producing weight  
loss in the short-term but have not shown success in the long- 
term. Improvements for future competitions will be to 
increase the length of the weight loss competition, 
investigate reasons for patient dropout, provide standardized 
definitions for the lifestyle modifications and to implement 
the competition multiple times a year as an ongoing program 
adjunct to the EWP. Patient weights will continue to be 
monitored through the EWP and future studies will assess the 
strength of the adjunct competitions in the long-term. 
 
The study was created with the goal of providing pharmacists 
with a tool to achieve patient weight loss beyond the 
possibility of a financial incentive as an endpoint. Prior to the 
beginning of the study and during the study patients 
developed many strategies to achieve personal goals through 
technology, social support and other various resources. When 
applying the competition to the Transtheoretical Model, 
developed by Prochaska and DiClemente, long-term studies 
could be performed to evaluate patient strategies for success 
and failure during the Maintenance phase and Relapse stages 
of change.34  Offering multiple 8-week competitions, would 
help patients in the Relapse stage restart the cycle and 
provide further information on patient success and failure in 
maintaining weight loss. Other studies evaluating success of 
financially incentivized weight loss programs do not address 
this model nor attempt to evaluate success and failure 




The implementation of a financially incentivized weight loss 
competition provided significant short-term weight loss to a 
patient population that was already enrolled in an  
established pharmacist-directed EWP who had not shown 
clinical improvement prior to the intervention. Overall the 
patients were satisfied, felt healthier, and agreed to continue 
following the recommendations of the program. The adjunct 
program will continue to be utilized in the EWP with clinical 
monitoring and pharmacist coaching to allow all patients an 
interactive tool shown to facilitate healthy weight loss 
through financial incentives and competition. 
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Figure 1. Healthy lifestyle practices points log 
WEEK #_   MON TUES WED THURS FRI SAT SUN 
1 point: Contact with Teammate        
3 points: 64 Kunces of tater        
3 points: Avoid   ating   fter 9 pm        
3 points: 2 Fruit Servings        
5 points: 3 Vegetable Servings        
5 points: No Sweets/Sugary Treats 
(Only 6 days a week) 
       
5 points: Keep a Food Journal        
5 points: 30 min.  xercise OR        
7 points: 45 min.  xercise 
(Only 5 days a week) 
       
TOTAL POINTS:        
(205 possible for the week)        
 
Lowest Recorded Weight: Weight on Monday Dorning of Week : _ 
 
Grand Total of Points from Week :    
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Table 1. Baseline patient demographics n (%) 
Number of patients 24 (100) 
Sex 
Female 18 (75.0) 
Male 6 (25.0) 
Race 
Caucasian 23 (95.8) 
African-American 1 (4.2) 
Highest level of education 
High school graduate 4 (16.7) 
Some college or vocational school 7 (29.2) 
College graduate 2 (8.3) 
Post-graduate or professional school 11 (45.8) 
Exercise 
Never exercise 4 (16.7) 
Less than 1 time per week 4 (16.7) 
1-2 times per week 7 (29.2) 
3 times per week 1 (4.2) 
4 times per week 1 (4.2) 
5+ times per week 5 (20.8) 
No response 2 (8.2) 
Age Mean ± SD 
Years 38.6 ± 10.9 
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  competition   
Post-weight 
loss 
competition   
Mean difference 
(95% CI) Pa 
All patients (n=24) 
Total cholesterol (mg/dL) 163.4±36.8 169.2±32.4 5.8 (-5.4 to 17) 0.302 
LDL-C (mg/dL) 94.2±32.8 100.5±28.1 6.3 (-2.5 to 15.2) 0.153 
HDL-C (mg/dL) 45.7±13.7 45.9±11.7 0.2 (-3.1 to 3.6) 0.899 
Triglycerides (mg/dL) 129.0±44.4 114.04±52.9 -14.5 (-29.0 to 0.1) 0.101 
Systolic blood pressure (mmHg) 119.1±9.6 118.2±10.3 -0.9 (-5.2 to 3.4) 0.660 
Diastolic blood pressure (mmHg) 76.9±8.7 76.7±8.9 -0.2 (-4.4 to 4.0) 0.917 
Weight (lb) 206.9±37.0 196.9±32.4 -10.0 (-13.1 to -6.8) <0.001 
BMI (kg/m2) 32.0±6.3 30.4±5.9 -1.6 (-2.1 to -1.1) <0.001 
≥1600 points (n=10) 
Total cholesterol (mg/dL) 181.5±44.2 170.8±41.3 -10.7 (-26.1 to 4.7) 0.151 
LDL-C (mg/dL) 111.9±39.6 107.4±34.3 -4.5 (-19.6 to 10.6) 0.520 
HDL-C (mg/dL) 44.9±8.3 44.8±6.5 -0.1 (-7.5 to 7.3) 0.977 
Triglycerides (mg/dL) 128.3±35.6 91.4±35.8 -36.9 (-49.1 to 24.7) <0.001 
Systolic blood pressure (mmHg) 115.3±7.8 115.2±7.7 -0.1 (-7.9 to 7.7) 0.977 
Diastolic blood pressure (mmHg) 73.9±9.5 71.6±6.7 -2.3 (-7.8 to 3.2) 0.372 
Weight (lb) 221.3±26.8 206.4±25.6 -14.9 (-20.6 to -9.2) <0.001 
BMI (kg/m2) 33.8±6.1 31.5±5.7 -1.0 (-3.2 to -1.4) <0.001 
<1600 points (n=14) 
Total cholesterol (mg/dL) 150.5±24.7 168.1±26.0 17.6 (3.2 to 31.9) 0.020 
LDL-C (mg/dL) 81.6±20.1 107.4±34.3 14.1 (3.5 to 24.6) 0.013 
HDL-C (mg/dL) 46.2±16.9 46.6±14.5 0.4 (-3.1 to 4.0) 0.799 
Triglycerides (mg/dL) 129±51.1 130.2±58.2 1.6 (-24.9 to28.0) 0.899 
Systolic blood pressure (mmHg) 121.8±10.0 120.3±11.6 -1.5 (-7.4 to 4.4) 0.592 
Diastolic blood pressure (mmHg) 79.1±7.66 80.4±8.6 1.3 (-5.2 to 7.8) 0.674 
Weight (lb) 196.6±40.7 190.1±40.2 -6.4 (9.0 to 3.9) <0.001 
BMI (kg/m2) 30.7±6.4 29.6±6.1 -1.0 (-1.5 to -0.6) <0.001 
AbbreviationƐ: CI, Confidence Interval; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; 
BMI, body mass index 
a Paired two-tailed t test, P < 0.05 considered statistically significant 
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Table 3. Correlation between points earned and clinical data 
 Clinical data (n=24) ra Pb 
 Total cholesterol (mg/dL) -0.542 0.006 
 LDL-C (mg/dL) -0.500 0.013 
 HDL-C (mg/dL) -0.144 0.500 
 Triglycerides (mg/dL) -0.488 0.016 
 Systolic blood pressure (mmHg) 0.019 0.930 
 Diastolic blood pressure (mmHg) -0.256 0.230 
 Weight (lb) -0.887 <0.001 
 BMI (kg/m2) -0.888 <0.001 
Abbreviations: LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; BMI, body mass 
index 
a Pearson (r) correlation coefficient between points earned and clinical readings 








Table 4. Patient satisfaction with the weight loss competition (n=24)a  
Question Mean SD 
Did you find the program directions easy to follow? 4.4 0.7 
Would you recommend a similar program to friends or family? 4.4 0.8 
Will you continue to follow the recommendations of the program? 4.2 0.8 
Do you feel healthier after participating in the program? 4.1 0.9 
Will you participate in the program again? 4.3 0.9 
Are you satisfied with your results? 3.9 1.0 
Abbreviation: SD, standard deviation 
a Likert Scale: 1 (Strongly Disagree), 2 (Disagree), 3 (Neutral), 4 (Agree), 5 (Strongly Agree) 
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